Publication:
Transforming rhinacanthin analogues from potent anticancer agents into potent antimalarial agents

dc.contributor.authorNgampong Kongkathipen_US
dc.contributor.authorNarathip Pradidpholen_US
dc.contributor.authorKomkrit Hasitapanen_US
dc.contributor.authorRonald Griggen_US
dc.contributor.authorWei Chun Kaoen_US
dc.contributor.authorCarola Hunteen_US
dc.contributor.authorNicholas Fisheren_US
dc.contributor.authorAshley J. Warmanen_US
dc.contributor.authorGiancarlo A. Biaginien_US
dc.contributor.authorPalangpon Kongsaereeen_US
dc.contributor.authorPitak Chuawongen_US
dc.contributor.authorBoonsong Kongkathipen_US
dc.contributor.otherKasetsart Universityen_US
dc.contributor.otherUniversity of Leedsen_US
dc.contributor.otherLiverpool School of Tropical Medicineen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-09-24T08:47:23Z
dc.date.available2018-09-24T08:47:23Z
dc.date.issued2010-03-01en_US
dc.description.abstractTwenty-six novel naphthoquinone aliphatic esters were synthesized by esterification of 1,4-naphthoquinone alcohols with various aliphatic acids. The 1,4-naphthoquinone alcohols were prepared from 1-hydroxy-2-naphthoic acid in nine steps with excellent yields. Twenty-four of the novel synthetic naphthoquinone esters showed significant antimalarial activity with IC 50 values in the range of 0.03-16.63 μM. The length of the aliphatic chain and the presence of C-2′ substituents on the propyl chain affected the activity. Interestingly, compounds 31 and 37 showed very good antimalarial activity and were not toxic to normal Vero cells, and the PTI values of 31 (> 1990.38) and 37 (1825.94) are excellent. Both 31 and 37 showed potent inhibition against P. falciparum 3D7 cyt bc1 and no inhibition on rat cyt bc1. They showed IC50 values in the nanomolar range, providing full inhibition of cyt bc1 with one molecule inhibitor bound per cyt bc1 monomer at the Qo site. © 2010 American Chemical Society.en_US
dc.identifier.citationJournal of Medicinal Chemistry. Vol.53, No.3 (2010), 1211-1221en_US
dc.identifier.doi10.1021/jm901545zen_US
dc.identifier.issn15204804en_US
dc.identifier.issn00222623en_US
dc.identifier.other2-s2.0-77249142352en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/28775
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77249142352&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleTransforming rhinacanthin analogues from potent anticancer agents into potent antimalarial agentsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77249142352&origin=inwarden_US

Files

Collections